Faculty profile

Maria Davola

Back to faculty

Assistant Professor (Part-Time)MedicineMcMaster University

Maria Davola

Assistant Professor (Part-Time)

Medicine

Faculty of Health Sciences

McMaster University

Hamilton, Ontario, Canada

In this role since 2025

Email ORCID

Supervision signals

Adjunct, part-time and visiting faculty usually co-supervise alongside a core faculty member.
No graduate courses on record.
7 publications in the last five years, latest in 2025.

These signals come from public records. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

296

Citations

h-index

Collaborators

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Academic profiles

University Profile Search on Google Scholar iDORCID OpenAlex

Social profiles

𝕏Search on X inSearch on LinkedIn 🦋Search on Bluesky ▶Search on YouTube

Contact

davolam@mcmaster.ca

Research

Research areas, by share of publications

Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology
Herpesvirus Infections and TreatmentsMedicine
Immunotherapy and Immune ResponsesImmunology and Microbiology
Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology

Research areas are derived from OpenAlex topics of their publications.

11 publications.

Humanized mouse models of KRAS-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies

Davola ME, Cormier O, Lepard M, McNicol J, Collins S, Hammill JA, Silvestri C, Bramson JL, Gillgrass A, Mossman KL

OncoImmunology20256 citationsFirst author

DOI: 10.1080/2162402x.2025.2473163

Antiviral humoral immunity: Enemy or ally of viral immunotherapy?

Davola ME, Cormier O, Mossman K

Seminars in Immunology20251 citationsFirst author

DOI: 10.1016/j.smim.2025.102001

Evaluating transcriptional tumour microenvironment response to immunotherapy using microarray analysis: From harvesting tumours to data analysis

Cormier O, Davola ME, Collins S, Mossman K

Methods in Cell Biology2025

DOI: 10.1016/bs.mcb.2025.01.004

Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy

Baracuhy EM, Cormier O, Davola ME, Collins S, Mossman K

Molecular Therapy: Oncolytics20244 citations

DOI: 10.1016/j.omton.2024.200906

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells

Davola ME, Cormier O, Vito A, El-Sayes N, Collins S, Salem O, Revill S, Ask K, Wan Y, Mossman K

Cancers202315 citationsFirst authorOpen Access

DOI: 10.3390/cancers15041295 PMID: W4321378235

Covalent Immune Proximity-Induction Strategy Using SuFEx-Engineered Bifunctional Viral Peptides

McCann HM, Lake BPM, Hoffman KS, Davola ME, Mossman KL, Rullo AF

ACS Chemical Biology202226 citations

DOI: 10.1021/acschembio.2c00233

Visualizing Early HCoV-229E Viral Infection Events Using Correlative 2D Light and 3D Electron Microscopy Techniques

Williams A, Davola M, Mossman K, Grandfield K, Phaneuf MW, Bassim N

Microscopy and Microanalysis2022

DOI: 10.1017/s1431927622006146 PMID: W4286470614

AHR signaling is induced by infection with coronaviruses

Giovannoni F, Li Z, Remes-Lenicov F, Dávola ME, Elizalde M, Paletta A, Ashkar AA, Mossman KL, Dugour AV, Figueroa JM

Nature Communications202186 citationsOpen Access

DOI: 10.1038/s41467-021-25412-x PMID: W3195151522

Genetic modification of oncolytic viruses to enhance antitumor immunity

Davola ME, Vito A, Wei J, El-Sayes N, Workenhe S, Mossman KL

Methods in Enzymology20205 citationsFirst author

DOI: 10.1016/bs.mie.2019.05.017

Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?

Davola ME, Mossman KL

OncoImmunology2019144 citationsFirst author

DOI: 10.1080/2162402x.2019.1596006

Frequent collaborators

Co-authors at McMaster University. Thicker lines mean more shared papers.Explore the network

Kathryn Grandfield

Materials Science and Engineering

1 shared papers, latest 2022

Nabil Bassim

Materials Science and Engineering

1 shared papers, latest 2022

Researchers with similar interests

Karen Mossman

Medicine

Virus-based gene therapy research, Herpesvirus Infections and Treatments

Brian Lichty

Medicine

Virus-based gene therapy research, Immunotherapy and Immune Responses

Anna Rozenberg

Anesthesia

Virus-based gene therapy research

Jonathan Bramson

Medicine

Immunotherapy and Immune Responses, Virus-based gene therapy research

Charu Kaushic

Medicine

Herpesvirus Infections and Treatments

Dongdong Wang

Medicine

Natural product bioactivities and synthesis

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Virus-based gene therapy research Dear Professor Davola, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Humanized mouse models of KRAS-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies" (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Open in email

Something wrong or missing on this profile? Suggest a correction

Maria Davola

Research

Humanized mouse models of KRAS-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies

Antiviral humoral immunity: Enemy or ally of viral immunotherapy?

Evaluating transcriptional tumour microenvironment response to immunotherapy using microarray analysis: From harvesting tumours to data analysis

Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells

Covalent Immune Proximity-Induction Strategy Using SuFEx-Engineered Bifunctional Viral Peptides

Visualizing Early HCoV-229E Viral Infection Events Using Correlative 2D Light and 3D Electron Microscopy Techniques

AHR signaling is induced by infection with coronaviruses

Genetic modification of oncolytic viruses to enhance antitumor immunity

Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?

Frequent collaborators

Karen Mossman

Jonathan Bramson

Ali A Ashkar

Kjetil Ask

Kathryn Grandfield

Nabil Bassim

Researchers with similar interests

Karen Mossman

Brian Lichty

Anna Rozenberg

Jonathan Bramson

Charu Kaushic

Dongdong Wang